NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Himadri Speciality Chemicals Sees 14-Month High as Investors Flock to Shares

Shares of Himadri Speciality Chemicals surged 13% in Friday's intraday session on April 24, reaching a 14-month high of ₹605 apiece, as investors reacted positively to the company's performance in the March-ended quarter.

The company reported a 13.5% year-on-year (YoY) increase in consolidated revenue to ₹1,288 crore in its post-market hours release on Thursday. Earnings before interest, taxes, depreciation, and amortization (EBITDA) rose 21.15% YoY to ₹280 crore, with operating margin expanding to 21.74%. On the bottom line, net profit surged 33.5% YoY to ₹207.53 crore.

For the full FY26, the company reported revenue of ₹4,660.70 crore and EBITDA of ₹755.07 crore, reflecting a marginal 1% YoY revenue growth and a strong 36% YoY EBITDA growth, as per the company's earnings filing. The strong performance for the year was driven by stable volumes combined with higher margins, while the company's strategic focus on value-added products continued to support profitability growth.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

On Thursday, the company also announced the commissioning of its first anode material production facility at Mahistikry, West Bengal, with an initial capacity of 200 MTPA. This backward integration, along with proprietary process know-how, enables a fully integrated and self-reliant manufacturing ecosystem across the anode material value chain.

YearRevenue Growth (YoY)EBITDA Growth (YoY)
FY261%36%
FY25--

The company commenced operations at its new 70,000 MTPA Speciality Carbon Black line at Mahistikry, West Bengal, taking total carbon black capacity to 250,000 MTPA, of which 130,000 MTPA is dedicated to special carbon black.

Anurag Choudhary, CMD & CEO of Himadri Speciality Chemical, stated that the facility positions Mahistikry as the world's largest single-location speciality carbon black site and places Himadri among the top five global manufacturers in this segment. He added that this significantly strengthens the company's ability to serve high-value applications across batteries, plastics, inks, paints, coatings, and conductive solutions, reinforcing its leadership in speciality solutions.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

The company said its future growth will be driven by innovation-led R&D, which remains central to its strategy and business model. It added that the upcoming anthraquinone and carbazole facility is on track to be commissioned in the coming quarters, aiming to reduce India's dependence on imports of dyes and pigments.

The company also highlighted its focus on disciplined capital allocation to ensure sustainable returns and maintain a strong Return on Capital Employed (ROCE) profile. It further noted that Phase I of its LFP cathode material project is progressing as planned, with initial capacity expected by Q3FY27 and full operations targeted by FY29, its earnings filing showed.

Shares deliver 30% return in April The stock staged a strong rebound in April, gaining 30% so far, after delivering muted returns over the previous three months. The rally has also helped push its year-to-date returns to 17.30%. Earlier this year, the stock touched a low of ₹421 apiece and has since rebounded by 45% at current levels, marking a sharp turnaround from a 17% decline in CY25.

Historically, the stock has delivered positive returns for four consecutive years from 2021 to 2024, with 2023 emerging as the best-performing year, recording a gain of 207%.

Investor Takeaway

Investors should consider Himadri Speciality Chemicals for its strong Q4 performance and strategic focus on value-added products.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.